Does septal rebound stretch measured by speckle tracking echocardiography predict volumetric and neurohormonal response to cardiac resynchronization therapy in patients undergoing CRT implantation?
Septal rebound stretch measured by speckle tracking echocardiography is a sensitive index that predicts volumetric and neurohormonal response to cardiac resynchronization therapy.
AIMS: To develop a novel myocardial deformation index that is highly sensitive to the effect of cardiac resynchronization therapy (CRT) and that can be used to predict response to CRT. METHODS AND RESULTS: Before and 6.5 +/- 2.3 months after implantation of a CRT device, longitudinal shortening and stretch were timed and quantified by speckle tracking echocardiography in a cohort of 62 patients. Distinction was made between systolic total stretch (STS; all systolic stretch) and systolic rebound stretch (SRS; only systolic stretch following initial shortening). Systolic total stretch and SRS could be measured in all wall segments in 41 of 62 patients. Septal SRS quantification was possible in all 62 patients and was performed by a blinded observer. Cardiac resynchronization therapy reduced STS (-55 +/- 30%) but reduced SRS (-77 +/- 21%) significantly more (P or=15% with a sensitivity and specificity of 81% at ROC analysis (areas under the curve 0.89 +/- 0.04). CONCLUSION: Septal rebound stretch appears to be a sensitive and practical diagnostic criterion to quantify the functional substrate amenable to CRT and to predict response.
Boeck et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: